Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2018 Mar;98(3):653–655. doi: 10.4269/ajtmh.17-0657

Parasite–Vector Interaction of Chagas Disease: A Mini-Review

Ana Beatriz Bortolozo de Oliveira 1, Kaio Cesar Chaboli Alevi 1,2,*, Carlos Henrique Lima Imperador 1, Fernanda Fernandez Madeira 1, Maria Tercília Vilela de Azeredo-Oliveira 1
PMCID: PMC5930897  PMID: 29514731

Abstract.

Trypanosoma cruzi is a protozoan of great importance to public health: it has infected millions of people in the world and is the etiologic agent of Chagas disease, which can cause cardiac and gastrointestinal disorders in patients and may even lead to death. The main vector of transmission of this parasite is triatomine bugs, which have a habit of defecating while feeding on blood and passing the parasite to their own hosts through their feces. Although it has been argued that T. cruzi is not pathogenic for this vector, other studies indicate that the success of the infection depends on several molecules and factors, including the insect’s intestinal microbiota, which may experience changes as a result of infection that include decreased fitness. Moreover, the effects of infection depend on the insect species, the parasite strain, and environmental conditions involved. However, the parasite–vector interaction is still underexplored. A deeper understanding of this relationship is an important tool for discovering new approaches to T. cruzi transmission and Chagas disease.


The Trypanosoma cruzi (Chagas, 1909) protozoan is a parasite belonging to the order Kinetoplastida and the family Trypanosomatidae that acts as an etiologic agent of Chagas disease.1 Also known as American trypanosomiasis, this disease is neglected2 and potentially life-threatening3; although most infected individuals are asymptomatic and do not exhibit clinical symptoms of the disease, 30–40% of patients develop cardiac diseases, gastrointestinal disorders, or both.4 The treatment available consists of benznidazole and nifurtimox, but the effectiveness of both drugs decreases as the time after infection increases; ideally, treatment is administered in the early acute phase. In addition, these drugs cannot be used by pregnant women or patients with neurological or psychiatric disorders.3 Although there is still a considerable lack of interest among pharmaceutical companies to perform research and create programs to combat Chagas disease, this illness represents a major public health problem. It is the most prevalent parasitic disease in the Americas and makes an important contribution to morbidity and mortality rates in countries where it is endemic.5

It is estimated that approximately 6,000,000–7,000,000 people worldwide are infected with T. cruzi, and most cases are located in Latin America.3 However, Chagas disease has spread to nonendemic areas and has been reported in countries such as Canada, the United States, Japan, Australia, New Zealand, Switzerland, Italy, and Spain.6 This spread arises from the congenital transmission of the parasite or through contaminated blood transfusions. Although T. cruzi transmission can also occur during infected donor organ transplantation, laboratory accidents, or the ingestion of contaminated food, the main transmission pathway of this parasite is through a vector: triatomine insects.7,8 Triatomines have a habit of defecating while feeding on blood and, if they are infected with T. cruzi, the parasite is released through the feces in infectious form (trypomastigotes).9

Triatomines have hemimetabolous development, which includes an egg phase, five nymphal stages and, finally, the adult phase. Hematophagy occurs in all stages after hatching, and the insects usually bite at night.10 These bugs belong to the order Hemiptera, the suborder Heteroptera, the family Reduviidae, and the subfamily Triatominae. The 152 known species of triatomine bugs are divided into 18 genera and 5 tribes,1115 all of which have the potential to act as T. cruzi vectors. Enhancing the knowledge on the relationship between the parasite and these vector species may aid in the creation of simple techniques for diagnosing triatomine infections, such as xenodiagnosis. The rate of infectivity seems to vary between species of triatomine bugs, and it has been shown that, although the domestic species are of immense importance in the transmission of the parasite, it is the wild vectors which have higher levels of infectivity.16

There are seven discrete typing units of T. cruzi classified based on different molecular markers,17 namely TcI, TcII, TcIII, TcIV, TcV, TcVI, and TcVII.18,19 This protozoan is known to be harmful to humans and other mammals. Although it has been argued that this species is not pathogenic for its triatomine hosts, small changes in insect fecundity can harm host fitness, as observed in a study on Panstrongylus megistus (Burmeister, 1835). The study found that development, mortality rates, and the time between molting periods in the infected group were similar to those of the control group; however, the number of eggs laid by infected females was 3.5 times lower, and the infected group exhibited a decrease in both the number of fertile eggs and the hatching rate.20 However, knowledge on the parasite–vector relationship is still very scarce and some of the available information is poorly understood or conflicting.21 Although the relationship between these organisms is generally considered harmonious and although T. cruzi does not seem to be pathogenic to its invertebrate hosts, some studies have reported adverse effects of this infection,21 and this finding will be discussed in this mini-review.

Studies indicate that bacteria play a protective role against T. cruzi in triatomines. Intestinal microbiota composition can interfere with infection effectiveness, and a test showed that use of antibiotics made it easier for the parasite to increase its competence in the intestine of Rhodnius prolixus Stål, 1859.22 The success of the infection appears to depend on a balance between the microorganism and protozoan populations because both compete for resources in the intestine; furthermore, microbiota can indirectly increase the expression of antiparasitic molecules and induce immune response in the insect.23 However, sequencing and analysis of the R. prolixus genome suggest that either the insect immune system is not affected by T. cruzi, or the parasite is not affected by antimicrobial peptides produced as a consequence of the infection. These findings indicate that T. cruzi developed avoidance or tolerance mechanisms against invertebrate host defenses.24

In addition, the dynamic control of epimastigote and trypomastigote populations is crucial for the parasite to be able to colonize the insect gut, because T. cruzi is exposed to different environments during its life cycle, including different digestive tracts and different invertebrate hosts.25 For the parasite to adapt to different parts of the insect and for infection to be achieved, several factors and molecules are necessary. Evidence indicates that physiological molecules with antagonistic redox status assist in the proliferation and differentiation of T. cruzi.26 Oxidant molecules such as heme stimulate the proliferation of noninfective epimastigotes,27,28 and antioxidant molecules such as urate promote metacyclogenesis, an event in which epimastigotes create infective and nonproliferative trypomastigote forms.29 Thus, a clearer understanding of the role of these molecules in the interaction between these organisms is an important target for the development of strategies for treating Chagas disease.26

In a study comparing Triatoma infestans (Klug, 1834) specimens infected with T. cruzi in the first feeding after hatching to uninfected triatomines used as control, there was no significant increase in mortality rates or any developmental delays in the insects.30 Another study found that in the same triatomine species, colonization by the parasite does not cause harmful changes to the intestinal tissue.31 On the other hand, numerous physiological, morphological, and behavioral factors of an organism can be modified when it hosts a parasite. For example, infection by T. cruzi increases the ability of Mepraia spinolai (Porter, 1934) hosts to detect vertebrate and decreases their time between feeding and defecation. These changes are likely to enhance parasite transmission and, consequently, reflect the epidemiological importance of this vector in Chagas disease.32

Furthermore, Fellet et al.21 observed losses in reproductive performance in a study on R. prolixus. The parasite may reduce insect fitness and affect host survival.21,33,34 In addition, studies have found that infection by T. cruzi increased the mortality rate of M. spinolai, reduced the oviposition and hatching rate of P. megistus eggs, decreased reproductive fitness of R. prolixus under temperature conditions similar to those of the natural environment in which this species is found, and in the case of some strains, may have extended the molting period and reduced insect longevity.33 In another study, infected Triatoma dimidiata (Latreille, 1811) specimens were found to have larger wings than uninfected insects; these findings suggest a possible relationship between this difference in morphology and host dispersion potential, which could contribute to the protozoan transmission.34

Thus, the effects of T. cruzi on triatomines vary depending on different factors, including the parasite strain, the triatomine species, and the environmental conditions involved (including temperature and nutritional status). Therefore, the adverse effects described previously and on the limited amount of research specifically focused on the interactions between triatomines and T. cruzi show this is an area that can be studied in greater detail.33 Moreover, the best way to intervene in the transmission of this parasite is through its vector. Other studies, for example, have confirmed that treatment with azadirachtin decreases the total number of flagella and blocks metacyclogenesis,35 and there is evidence that this tetranortriterpenoid has different effects on different triatomine species and T. cruzi strains.36 Thus, research into the interactions between these organisms are likely to increase in the future, and a better understanding of different species’ interactions with this parasite can provide important information for the development of new approaches for the control of Chagas disease.37

Because metabolic interaction between an intracellular parasite and host cell is essential for colonization to be successful38 and because the relationship between parasites and vectors results in two-way interactions that impact other members of the vectors’ community, it is important to improve our knowledge and understanding of the influence of T. cruzi infection on triatomines.39 This parasite–vector relationship is relevant and should be explored further to increase the knowledge on the consequences of infection by this parasite, which is of great importance to public health in many countries.

Acknowledgments:

We appreciate the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) by the granted resources.

REFERENCES

  • 1.Chagas C, 1909. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1: 159–218. [Google Scholar]
  • 2.Liñares GEG, Ravaschino EL, Rodriguez JB, 2006. Progresses in the field of drug design to combat tropical protozoan parasitic diseases. Curr Med Chem 13: 335–360. [DOI] [PubMed] [Google Scholar]
  • 3.World Health Organization , 2015. Chagas disease (American trypanosomiasis). Wkly Epidemiol Rec 90: 33–44.25671846 [Google Scholar]
  • 4.Rassi A, Jr, Marin-Neto JA, 2010. Chagas disease. Lancet 375: 1388–1402. [DOI] [PubMed] [Google Scholar]
  • 5.Rodriguez JB, Falcone BN, Szajnman SH, 2016. Detection and treatment of Trypanosoma cruzi: a patent review (2011–2015). Expert Opin Ther Pat 26: 993–1015. [DOI] [PubMed] [Google Scholar]
  • 6.Soriano-Arandes A, Angheben A, Serre-Delcor N, Treviño-Maruri B, Gomez i Prat J, Jackson Y, 2016. Control and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practices. Trop Med Int Health 21: 590–596. [DOI] [PubMed] [Google Scholar]
  • 7.Angheben A, Boix L, Buonfrate D, Gobbi F, Bisoffi Z, Pupella S, Gandini G, Aprili G, 2015. Chagas disease and transfusion medicine: a perspective from non-endemic countries. Blood Transfus 13: 540–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Howard EJ, Xiong X, Carlier Y, Sosa-Estani S, Buekens P, 2014. Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol 121: 22–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Feder D, Gomes SAO, Freitas SC, Santos-Machado G, Santos-Mallet JR, 2014. The ultrastructural studies in parasite-vectors interactions. Méndez-Vilas A, ed. Microscopy: Advances in Scientific Research and Education. Spain: Formatex Research Center, 564–569. [Google Scholar]
  • 10.Jurberg J, Galvão C, 2006. Biology, ecology, and systematics of Triatominae (Heteroptera, Reduviidae), vectors of Chagas disease, and implications for human health. Biol Linz 50: 1096–1116. [Google Scholar]
  • 11.Galvão C, 2014. Vetores Da Doença de Chagas No Brasil. Curitiba, Brazil: Sociedade Brasileira de Zoologia. [Google Scholar]
  • 12.Alevi KCC, Reis YV, Guerra AL, Imperador CHL, Banho CA, Moreira FFF, Azeredo-Oliveira MTV, 2016. Would Nesotriatoma bruneri Usinger, 1944 be a valid species? Zootaxa 4103: 396–400. [DOI] [PubMed] [Google Scholar]
  • 13.Mendonça VJ, Alevi KCC, Pinotti H, Gurgel-Goncalves R, Pita S, Guerra AL, Panzera F, Araujo RF, Azeredo-Oliveira MTV, Da Rosa JA, 2016. Revalidation of Triatoma bahiensis Sherlock & Serafim, 1967 (Hemiptera: Reduviidae) and phylogeny of the T. brasiliensis species complex. Zootaxa 4107: 239–254. [DOI] [PubMed] [Google Scholar]
  • 14.Souza ES, Von Atzingen NCB, Furtado MB, Oliveira J, Nascimento JD, Vendrami DP, Gardim S, Rosa JA, 2016. Description of Rhodnius marabaensis sp. n. (Hemiptera, Reduviidae, Triatominae) from Pará State, Brazil. ZooKeys 621: 45–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rosa JA, Justino HHG, Nascimento JD, Mendonça VJ, Rocha CS, de Carvalho DB, Falcone R, Oliveira MTVA, Alevi KCC, de Oliveira J, 2017. A new species of Rhodnius from Brazil (Hemiptera, Reduviidae, Triatominae). ZooKeys 675: 1–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Perlowagora-Szumlewicz A, Muller CA, Moreira CJC, 1990. Studies in search of a suitable experimental insect model for xenodiagnosis of hosts with chagas’ disease 4—the reflection of parasite stock in the responsiveness of different vector species to chronic infection with different Trypanosoma cruzi stocks. Rev Saude Publica 24: 165–177. [DOI] [PubMed] [Google Scholar]
  • 17.Zingales B, et al. 2012. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol 12: 240–253. [DOI] [PubMed] [Google Scholar]
  • 18.Marcili A, Lima L, Cavazzana M, Junqueira AC, Veludo HH, Maia Da Silva F, Campaner M, Paiva F, Nunes VL, Teixeira MM, 2009. A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA. Parasitology 136: 641–655. [DOI] [PubMed] [Google Scholar]
  • 19.Zingales B, et al. 2009. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104: 1051–1054. [DOI] [PubMed] [Google Scholar]
  • 20.Lima MM, Pereira JB, Santos JAA, Pinto ZT, Braga MV, 1992. Development and reproduction of Panstrongylus megistus (Hemiptera: Reduviidae) infected with Trypanosoma cruzi, under laboratory conditions. Ann Entomol Soc Am 85: 458–461. [Google Scholar]
  • 21.Fellet MR, Lorenzo MG, Elliot SL, Carrasco D, Guarneri AA, 2014. Effects of infection by Trypanosoma cruzi and Trypanosoma rangeli on the reproductive performance of the vector Rhodnius prolixus. PLoS One 9: 26–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gumiel M, Mota FF, Rizzo VS, Sarquis O, Castro DP, Lima MM, Garcia ES, Carels N, Azambuja P, 2015. Characterization of the microbiota in the guts of Triatoma brasiliensis and Triatoma pseudomaculata infected by Trypanosoma cruzi in natural conditions using culture independent methods. Parasit Vectors 8: 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Buarque DS, Gomes CM, Araújo RN, Pereira MH, Ferreira RC, Guarneri AA, Tanaka AS, 2016. A new antimicrobial protein from the anterior midgut of Triatoma infestans mediates Trypanosoma cruzi establishment by controlling the microbiota. Biochimie 123: 138–143. [DOI] [PubMed] [Google Scholar]
  • 24.Mesquita RD, et al. 2016. Genome of Rhodnius prolixus, an insect vector of Chagas disease, reveals unique adaptations to hematophagy and parasite infection. Proc Natl Acad Sci USA 113: 14936–14941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dias FA, et al. 2015. Monitoring of the parasite load in the digestive tract of Rhodnius prolixus by combined qPCR analysis and imaging techniques provides new insights into the trypanosome life cycle. PLoS Negl Trop Dis 9: 1–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nogueira NP, et al. 2015. Proliferation and differentiation of Trypanosoma cruzi inside its vector have a new trigger: redox status. PLoS One 10: 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lara FA, et al. 2007. Heme requirement and intracellular trafficking in Trypanosoma cruzi epimastigotes. Biochem Biophys Res Commun 355: 16–22. [DOI] [PubMed] [Google Scholar]
  • 28.Paes MC, Cosentino-Gomes D, de Souza CF, Nogueira NP, Meyer-Fernandes JR, 2011. The role of heme and reactive oxygen species in proliferation and survival of Trypanosoma cruzi. J Parasitol Res 2011: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Schaub GA, Lösch P, 1988. Trypanosoma cruzi: origin of metacyclic trypomastigotes in the urine of the vector Triatoma infestans. Exp Parasitol 65: 174–186. [DOI] [PubMed] [Google Scholar]
  • 30.Schaub GA, 1988. Developmental time and mortality with Trypanosoma cruzi of larvae of Triatoma infestans infected. Trans R Soc Med Hyg 82: 94–96. [PubMed] [Google Scholar]
  • 31.Kollien AH, Schmidt J, Schaub GA, 1998. Modes of association of Trypanosoma cruzi with the intestinal tract of the vector Triatoma infestans. Acta Trop 70: 127–141. [DOI] [PubMed] [Google Scholar]
  • 32.Botto-Mahan C, Cattan PE, Medel R, 2006. Chagas disease parasite induces behavioural changes in the kissing bug Mepraia spinolai. Acta Trop 98: 219–223. [DOI] [PubMed] [Google Scholar]
  • 33.Guarneri AA, Lorenzo MG, 2017. Triatomine physiology in the context of trypanosome infection. J Insect Physiol 97: 66–76. [DOI] [PubMed] [Google Scholar]
  • 34.Nouvellet P, Ramirez-Sierra MJ, Dumonteil E, Gourbière S, 2011. Effects of genetic factors and infection status on wing morphology of Triatoma dimidiata species complex in the Yucatán peninsula, Mexico. Infect Genet Evol 11: 1243–1249. [DOI] [PubMed] [Google Scholar]
  • 35.Cortez MR, Provençano A, Silva CE, Mello CB, Zimmermann LT, Schaub GA, Garcia ES, Azambuja P, Gonzalez MS, 2012. Trypanosoma cruzi: effects of azadirachtin and ecdysone on the dynamic development in Rhodnius prolixus larvae. Exp Parasitol 131: 363–371. [DOI] [PubMed] [Google Scholar]
  • 36.Azambuja P, Garcia ES, 1992. Effects of azadirachtin on Rhodnius prolixus: immunity and Trypanosoma interaction. Mem Inst Oswaldo Cruz 87: 69–72. [DOI] [PubMed] [Google Scholar]
  • 37.Garcia ES, Genta FA, Azambuja P, Schaub GA, 2010. Interactions between intestinal compounds of triatomines and Trypanosoma cruzi. Trends Parasitol 26: 499–505. [DOI] [PubMed] [Google Scholar]
  • 38.Caradonna KL, Engel JC, Jacobi D, Lee CH, Burleigh BA, 2013. Host metabolism regulates intracellular growth of Trypanosoma cruzi. Cell Host Microbe 13: 108–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gourbière S, Dorn P, Tripet F, Dumonteil E, 2012. Genetics and evolution of triatomines: from phylogeny to vector control. Heredity 108: 190–202. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES